Eight H.B. Fuller ($FUL) directors have purchased approximately $1.12 million in stock near $50, following an earlier $295,000 purchase by CEO Celeste Mastin. Meanwhile, adjusted EPS jumped 21%, EBITDA margins reached a record 19.9%, and the stock trades at a forward P/E near 10×. Is this overlooked specialty adhesives manufacturer a compelling value opportunity—or a value trap? Our FunStock Index™: 8.0/10. 🧪📈

Read entire article

Bill Ackman is reshaping Howard Hughes Holdings ($HHH). The $2.1 billion acquisition of Vantage creates a new specialty insurance and reinsurance platform alongside valuable master-planned communities. Add $1.67 million in fresh executive buying, Pershing Square's approximately 46.6% stake and a potentially interesting valuation, and the investment thesis becomes fascinating. Is HHH evolving into a Berkshire-style compounder—or simply becoming more complicated? Our FunStock Index™: 8.2/10. 🏢⚡

Read entire article

Most furniture companies sell sofas.

Lovesac sells a platform.

Its modular Sactionals ecosystem encourages repeat purchases, customer loyalty, and long-term engagement while trading at valuation multiples that appear surprisingly inexpensive.

Read entire article

Revvity (RVTY) may not make flashy headlines, but it’s quietly building a powerful comeback story. With top institutions buying, analysts turning bullish, and profits stabilizing, this former PerkinElmer spinout is morphing into a biotech value gem. Here’s why investors — and scientists — are both smiling (in lab coats).

Read entire article

Nike’s been knocked down, but insiders and institutions aren’t ready to quit. With strong cash flow, consistent dividends, and that iconic swoosh, is it time to just do it—or jog the other way?

Read entire article